RxDoctor Payments Data
★ My doctorsLook up a doctor →

Roger Lyons

Hematology · San Antonio, TXNPI 1508838285

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $27,181 of the $43,585 with a category attached, or 62.4%. 51 manufacturers reported payments, led by Novartis at 30.8% of the total. Reporting peaked in 2020 at $12,528 and has fallen 97.2% since, to $350 in 2025. Among hematology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,585in general payments, 2019–2025

Across 345 payments — averaging $126.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$13K
  • Incyte Corporation$13K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K
  • UCB, Inc.$2K
  • Dova Pharmaceuticals$2K
  • Taiho Oncology, Inc.$2K
  • plus $7K from 45 others
$2,857,810in research payments, 2019–2025

Across 1,216 payments — averaging $2350.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$1.1M
  • Takeda Pharmaceuticals U.S.A., Inc.$840K
  • Otsuka Pharmaceutical Co., Ltd.$351K
  • Novartis$214K
  • Genentech, Inc.$146K
  • TG Therapeutics, Inc.$80K
  • plus $164K from 8 others

What the payments were for

  • Consulting fees$27,18162%
  • Speaking & faculty fees$7,64718%
  • Travel & lodging$9712%
  • Food & beverage$7,58217%
  • Education$2030%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis24$13,433
Incyte Corporation25$13,161
Takeda Pharmaceuticals U.S.A., Inc.3$3,241
UCB, Inc.1$2,450
Dova Pharmaceuticals5$2,404
Taiho Oncology, Inc.1$2,310
E.r. Squibb & Sons, L.L.C.33$593
Genentech USA, Inc.48$561
Johnson & Johnson(2 entities)20$493
AstraZeneca(2 entities)9$414
Sanofi11$404
Amgen18$387
Pfizer26$386
Merck19$335
AbbVie8$314
Verastem, Inc.9$248
Karyopharm Therapeutics Inc.3$176
Exelixis Inc.5$175
Eisai Inc.3$166
Astellas Pharma US Inc12$149
Bayer9$143
Rigel Pharmaceuticals, Inc.2$130
Genmab U.S., Inc.1$125
Immunogen, Inc.1$125
G1 Therapeutics, Inc.1$125
ADC Therapeutics America, Inc.1$122
Agios Pharmaceuticals, Inc.1$122
Lilly USA, LLC3$98
Tesaro, Inc.1$88
Puma Biotechnology, Inc.5$77
Seagen Inc.5$72
Boehringer Ingelheim4$61
Jazz Pharmaceuticals Inc.3$60
Daiichi Sankyo Inc.3$55
Tolmar Pharmaceuticals, Inc.3$42
Array Biopharma Inc2$33
AMAG Pharmaceuticals, Inc.2$32
Lexicon Pharmaceuticals, Inc.1$32
Gilead2$25
GSK1$24
EUSA Pharma (US) LLC1$23
Tersera Therapeutics LLC1$22
Apellis Pharmaceuticals, Inc.1$21
Stemline Therapeutics Inc.1$20
Sanofi-aventis U.S. LLC1$20
Bristol Myers Squibb1$18
Sandoz1$16
Helsinn Therapeutics (U.S.), Inc.1$14
Alnylam Pharmaceuticals Inc.1$14
EMD Serono, Inc.1$14
Teva Pharmaceuticals USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,585 in reported general payments places this provider in the 90th percentile of 97 hematology providers in Texas.

See all hematology providers in Texas →

Other hematology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →